| Net income | 594.3M |
| Depreciation and amortization | 163.6M |
| Net change in receivables sold under Receivables Securitization Facility | |
| Stock-based compensation expense | 35.5M |
| Change in contingent acquisition related obligations (Note 15) | |
| Excess tax benefits from stock-based compensation payment arrangements | -33.2M |
| Net change in components of working capital | |
| Net change in other long-term assets and liabilities | |
| Cash flow provided by operating activities | |
| Additions to property, plant and equipment | -136.3M |
| Purchases of short-term investments | -173.3M |
| Sales and maturities of short-term investments | |
| Acquisitions, net of cash acquired | -1.27B |
| Cash flow used in investing activities | |
| Borrowings under credit facilities | |
| Repayments under credit facilities | |
| Payments of fees and expenses related to debt financing | |
| Proceeds from exercise of stock options | 120.8M |
| Excess tax benefits from stock-based compensation payment arrangements | 33.2M |
| Payment of contingent acquisition related obligations | |
| Payments to shareholders of noncontrolling interests | |
| Purchase and retirement of treasury stock | -229.6M |
| Dividend payments | -129.4M |
| Cash flow (used in) provided by financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | |
| Net change in cash and cash equivalents | -883.6M |
| Cash and cash equivalents balance, beginning of period | 1.74B |
| Cash and cash equivalents balance, end of period | 853.6M |
| Interest | 65.2M |
| Income taxes | 192.4M |